113 related articles for article (PubMed ID: 11823045)
21. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
22. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.
Moscow JA; Huang H; Carter C; Hines K; Zujewski J; Cusack G; Chow C; Venzon D; Sorrentino B; Chiang Y; Goldspiel B; Leitman S; Read EJ; Abati A; Gottesman MM; Pastan I; Sellers S; Dunbar C; Cowan KH
Blood; 1999 Jul; 94(1):52-61. PubMed ID: 10381498
[TBL] [Abstract][Full Text] [Related]
23. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
[TBL] [Abstract][Full Text] [Related]
24. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
[TBL] [Abstract][Full Text] [Related]
25. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
Walsh CE; Mann MM; Emmons RV; Wang S; Liu JM
J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
[TBL] [Abstract][Full Text] [Related]
26. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
[TBL] [Abstract][Full Text] [Related]
27. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
Cornetta K; Croop J; Dropcho E; Abonour R; Kieran MW; Kreissman S; Reeves L; Erickson LC; Williams DA
Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue.
Zimmerman TM; Lee WJ; Bender JG; Schilling M; Smith SL; Van Epps DE; Williams SF
Bone Marrow Transplant; 2000 Sep; 26(5):505-10. PubMed ID: 11019839
[TBL] [Abstract][Full Text] [Related]
29. Retroviral transduction of murine and human hematopoietic progenitors and stem cells.
Ciuculescu MF; Brendel C; Harris CE; Williams DA
Methods Mol Biol; 2014; 1185():287-309. PubMed ID: 25062637
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.
Holmberg LA; Oparin DV; Gooley T; Lilleby K; Bensinger W; Reddish MA; MacLean GD; Longenecker BM; Sandmaier BM
Bone Marrow Transplant; 2000 Jun; 25(12):1233-41. PubMed ID: 10871727
[TBL] [Abstract][Full Text] [Related]
31. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
32. Transient gene expression mediated by integrase-defective retroviral vectors.
Yu SS; Dan K; Chono H; Chatani E; Mineno J; Kato I
Biochem Biophys Res Commun; 2008 Apr; 368(4):942-7. PubMed ID: 18279658
[TBL] [Abstract][Full Text] [Related]
33. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
Chabannon C; Cornetta K; Lotz JP; Rosenfeld C; Shlomchik M; Yanovitch S; Marolleau JP; Sledge G; Novakovitch G; Srour EF; Burtness B; Camerlo J; Gravis G; Lee-Fischer J; Faucher C; Chabbert I; Krause D; Maraninchi D; Mills B; Kunkel L; Oldham F; Blaise D; Viens P
Br J Cancer; 1998 Oct; 78(7):913-21. PubMed ID: 9764583
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
Alici E; Björkstrand B; Treschow A; Aints A; Smith CI; Gahrton G; Dilber MS
Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
[TBL] [Abstract][Full Text] [Related]
35. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
[TBL] [Abstract][Full Text] [Related]
36. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
37. Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M
Hum Gene Ther; 2001 Nov; 12(16):2023-5. PubMed ID: 11727734
[TBL] [Abstract][Full Text] [Related]
38. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
[TBL] [Abstract][Full Text] [Related]
39. The beta-galactosidase gene as a marker for hematopoietic reconstitution: individual cell analysis in a murine bone marrow transplantation model.
Dolnikov A; Millington M; Beruter E; Shounan Y; Symonds G
J Hematother Stem Cell Res; 2000 Oct; 9(5):659-72. PubMed ID: 11091490
[TBL] [Abstract][Full Text] [Related]
40. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
